MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Early experience using real-world monitoring to inform Parkinson’s management

    W. Chen, L. Kirkby, T. Jansen, G. Philips, T. Haynes, S. Little, J. Jiminez-Shahad, H. Zahed, P. Lin, R. Gilron (San Francisco, USA)

    Objective: To explore the utility of remote patient monitoring, using a combination of brain sensing and objective outcome measurement, in the management of Parkinson’s disease…
  • 2022 International Congress

    Serial Cases: Blepharospasm With Oromandibular Dystonia (Meige Syndrome) (Rare Case)

    NER. Raisa, ULA. Abshor (Malang, Indonesia)

    Objective: Meige syndrome is a type of cranial dystonia characterized by blepharospasm and oromandibular dystonia and can be associated with complex movements of the muscles…
  • 2022 International Congress

    Evaluation of hyperintense globus pallidus rim sign in seven-tesla MRI as a diagnostic biomarker in Wilson’s disease

    D. Su, Z. Zhang, Z. Zhang, T. Wu, J. Jing, T. Feng (Beijing, China)

    Objective: We aim to study the sensitivity and specificity of hyperintense globus pallidus rim sign in WD diagnosis. Background: The diagnosis of Wilson disease (WD)…
  • 2022 International Congress

    Dopaminergic modulation of express reaching responses in Parkinson’s disease

    M. Gilchrist, R. Kozak, B. Corneil, P. Macdonald (London, Canada)

    Objective: This study investigates the role of dopamine (DA) in modulation of automatic stimulus-driven responses. We investigated the effect of PD, DA medication, and instruction…
  • 2022 International Congress

    White Matter Correlates of Physical Therapy Measures in Parkinson’s disease Patients with Freezing of Gait

    V. Mishra, J. Longhurst, K. Sreenivasan, D. Cordes, A. Ritter, Z. Mari (Las Vegas, USA)

    Objective: To identify white-matter (WM) correlates of physical therapy (PT)-measures in Parkinson’s disease (PD) patients with freezing of gait (FOG). Background: Significant gap remains in…
  • 2022 International Congress

    Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD)

    E. Brown, D. Alonso, L. Chahine, C. Coffey, R. Dobkin, M. Korell, A. Lorenzo, C. Marras, W. Poewe, T. Sherer, A. Siderowf, T. Simuni, E. Tolosa, J. Valverde Twiggs, D. Weintraub, S. Chowdhury, K. Marek, C. Tanner (San Francisco, USA)

    Objective: To establish a large, longitudinal online cohort linked with a selected, intensively assessed cohort of people with and without PD to characterize development and…
  • 2022 International Congress

    Botulinum Toxin Therapy for Medication and DBS Refractory Foot Dystonia of Parkinsonism

    E. Zinoviev, M. Ganapathy, M. Siddiqui (Winston-Salem, USA)

    Objective: To determine efficacy and safety of BTX therapy in patients with medically refractory foot dystonia secondary to Parkinson’s disease (PD) or atypical Parkinsonism (AP)…
  • 2022 International Congress

    Late-onset cerebellar ataxia: case report of a new CNV on TTBK2 gene as possible cause of SCA-11

    I. Rodríguez (Monterrey, Mexico)

    Objective: To describe a case of  spinocerebellar ataxia type 11 caused by the copy number variant 43008859_43075833 on the TKKB2 gene Background: The spinocerebellar ataxias…
  • 2022 International Congress

    Diagnostic Accuracy of Parkinson’s disease: Where Do We Stand?

    S. Virameteekul (London, United Kingdom)

    Objective: To provide an up-to-date assessment of diagnostic accuracy parameters at early and late stages of the diagnosis in clinical practice and MDS Diagnostic Criteria…
  • 2022 International Congress

    A systematic review of Movement Disorders in COVID-19

    K. Pillai, S. Mishra, G. Siripurapu, A. Aliyar, R. Rajan, A. Srivastava, D. Radhakrishnan (Kochi, India)

    Objective: We conducted a systematic review to describe the frequency, clinical profile and outcomes of patients with SARS-CoV-2 associated movement disorders. Background: SARS-CoV-2 is associated…
  • « Previous Page
  • 1
  • …
  • 766
  • 767
  • 768
  • 769
  • 770
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley